We are live on ! Find out more
AG

Algert Global Portfolio holdings

AUM $6.65B
1-Year Est. Return 53.68%
This Fund
S&P 500
This Quarter Est. Return
+11.57%
1 Year Est. Return
+53.68%
3 Year Est. Return
+140.8%
5 Year Est. Return
+204.57%
10 Year Est. Return
+1,528.09%
AUM
$3.72B
AUM Growth
+$712M
Cap. Flow
+$438M
Cap. Flow %
11.77%
Top 10 Hldgs %
5.36%
Holding
1,675
New
193
Increased
556
Reduced
337
Closed
523

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$27.2M
2
MSFT icon
Microsoft
MSFT
+$25.4M
3
NVDA icon
NVIDIA
NVDA
+$19.1M
4
AMZN icon
Amazon
AMZN
+$14.8M
5
ATKR icon
Atkore
ATKR
+$10.5M

Top Sells

Rank Stock Value
1
GMS
GMS Inc
GMS
+$11.7M
2
GPI icon
Group 1 Automotive
GPI
+$10.4M
3
VGR
Vector Group Ltd.
VGR
+$8.79M
4
LNTH icon
Lantheus
LNTH
+$8.06M
5
DRVN icon
Driven Brands
DRVN
+$8.02M

Sector Composition

Rank Sector Weight
1 Industrials 16.39%
2 Technology 15.78%
3 Financials 14.3%
4 Healthcare 13.38%
5 Consumer Discretionary 12.73%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CUBI icon
576
Customers Bancorp
CUBI
$2.57B
$1.83M 0.05%
39,449
-43,863
-53% -$2.28M
MSA icon
577
Mine Safety
MSA
$6.72B
$1.83M 0.05%
10,331
-11,890
-54% -$2.16M
CBRE icon
578
CBRE Group
CBRE
$39.7B
$1.83M 0.05%
+14,693
New +$1.6M
CTKB icon
579
Cytek Biosciences
CTKB
$589M
$1.82M 0.05%
329,375
+34,100
+12% +$193K
COOP
580
DELISTED
Mr. Cooper
COOP
$1.82M 0.05%
19,764
-4,490
-19% -$398K
IONS icon
581
Ionis Pharmaceuticals
IONS
$9.23B
$1.82M 0.05%
45,430
-29,920
-40% -$1.39M
SPSC icon
582
SPS Commerce
SPSC
$2.17B
$1.82M 0.05%
9,375
-9,300
-50% -$1.83M
NEXT icon
583
NextDecade
NEXT
$2.11B
$1.82M 0.05%
386,142
+271,458
+237% +$1.64M
NARI
584
DELISTED
Inari Medical, Inc. Common Stock
NARI
$1.82M 0.05%
44,106
+12,180
+38% +$585K
PCG icon
585
PG&E
PCG
$38.6B
$1.82M 0.05%
91,868
+68,979
+301% +$1.29M
RVMD icon
586
Revolution Medicines
RVMD
$40.1B
$1.82M 0.05%
40,048
HGV icon
587
Hilton Grand Vacations
HGV
$3.81B
$1.81M 0.05%
49,896
-6,440
-11% -$249K
GERN icon
588
Geron
GERN
$930M
$1.79M 0.05%
395,071
+268,000
+211% +$1.22M
QTRX icon
589
Quanterix
QTRX
$185M
$1.79M 0.05%
137,833
+59,496
+76% +$795K
BRSL
590
Brightstar Lottery PLC
BRSL
$1.9B
$1.78M 0.05%
83,750
-69,942
-46% -$1.5M
VZ icon
591
Verizon
VZ
$183B
$1.78M 0.05%
+39,651
New +$1.65M
V icon
592
Visa
V
$669B
$1.78M 0.05%
+6,466
New +$1.75M
CFLT
593
DELISTED
Confluent
CFLT
$1.77M 0.05%
+87,080
New +$1.95M
ACCO icon
594
Acco Brands
ACCO
$362M
$1.77M 0.05%
323,538
+22,308
+7% +$113K
FLGT icon
595
Fulgent Genetics
FLGT
$567M
$1.77M 0.05%
81,440
AI icon
596
C3.ai
AI
$1.27B
$1.77M 0.05%
72,936
+35,960
+97% +$914K
PRLB icon
597
Protolabs
PRLB
$1.87B
$1.77M 0.05%
60,137
-2,727
-4% -$83.2K
UNH icon
598
UnitedHealth
UNH
$385B
$1.76M 0.05%
+3,015
New +$1.71M
GES
599
DELISTED
Guess Inc
GES
$1.76M 0.05%
87,468
-3,830
-4% -$81.3K
WEX icon
600
WEX
WEX
$5.94B
$1.76M 0.05%
8,380
-12,260
-59% -$2.28M

Similar funds

Algert Global's Q3 2024 Portfolio in Review

As of Q3 2024, Algert Global held 1,675 positions worth $3.72B, up 24% from $3.01B the previous quarter. Its ten largest holdings account for 5.4% of the portfolio.

Algert Global deployed $438M of net new capital in Q3 2024, opening 193 new positions and adding to 556 existing holdings. Its largest new stake was Microsoft: 59,462 shares worth $25.6M.

By sector, the portfolio is most concentrated in Industrials at 16% of assets, down from 18% a quarter earlier, followed by Technology and Financials.

On the sell side, the largest reduction was GMS Inc, an estimated $11.7M trimmed.

  • Algert Global's largest Q3 2024 buy was Microsoft: 59,462 shares worth $25.6M.
  • Algert Global added most to Apple in Q3 2024, an estimated $27.2M increase.
  • Algert Global's biggest Q3 2024 reduction was GMS Inc, cutting an estimated $11.7M.
  • Algert Global fully exited Axcelis in Q3 2024, selling an estimated $7.53M.
  • Algert Global's ten largest holdings make up 5.4% of its $3.72B portfolio in Q3 2024.
  • Algert Global opened 193 new positions and closed 523 in Q3 2024.
  • Algert Global's portfolio value rose 24% quarter-over-quarter to $3.72B.

Based on Algert Global's 13F filing for Q3 2024, filed 12 Nov 2024.